Case of metastatic basal cell carcinoma to bone marrow, resulting in myelophthisic anemia

American Journal of Dermatopathology

Volumn 35, Issue 2, 2013, Pages

  Pham, Catherine M ^a   Syed, Almas A ^a   Siddiqui, Huma A ^b   Keller, Richard A ^b   Kowalewski, Catherine ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Basal cell carcinoma; Metastatic; Non melanoma skin cancer

Indexed keywords

CISPLATIN; LACTATE DEHYDROGENASE; PACLITAXEL; VISMODEGIB;

ADULT; ANEMIA; ARTICLE; BASAL CELL CARCINOMA; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CASE REPORT; CLINICAL EVALUATION; DRUG WITHDRAWAL; EXCISION; FOLLOW UP; HUMAN; LABORATORY DIAGNOSIS; MALE; METASTASIS; MYELOPHTHISIC ANEMIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; TUMOR CELL;

ANEMIA, MYELOPHTHISIC; BONE MARROW NEOPLASMS; CARCINOMA, BASAL CELL; HUMANS; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 84878954297     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3182761362     Document Type: Article

References (19)

1. Brougham ND, Dennett ER, Tan ST. Changing incidence of non-melanoma skin cancer in New Zealand. ANZ J Surg. 2011;81:633-636.
2. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353:2262-2269.
3. James W, Elston D, Berger T. Andrew's Diseases of the Skin: Clinical Dermatology. 11th ed. Saunders Elsevier; 2011.
4. Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005;294:681-690.
5. Lattes R, Kessler RW. Metastasizing basal-cell epithelioma of the skin; report of two cases. Cancer. 1951;4:866-878.
6. Wong CS, Strange RC, Lear JT. Basal cell carcinoma. BMJ. 2003;327: 794-798.
7. Snow SN, Sahl W, Lo JS, et al. Metastatic basal cell carcinoma. Report of five cases. Cancer. 1994;73:328-335.
8. Ting PT, Kasper R, Arlette JP. Metastatic basal cell carcinoma: report of two cases and literature review. J Cutan Med Surg. 2005;9:10-15.
9. Coletta DF, Haentze FE, Thomas CC. Metastasizing basal cell carcinoma of the skin with myelophthisic anemia. Cancer. 1968;22:879-884.
10. Kleinberg C, Penetrante RB, Milgrom H, et al. Metastatic basal cell carcinoma of the skin. Metastasis to the skeletal system producing myelophthisic anemia. J Am Acad Dermatol. 1982;7:655-659.
11. Schwartz RA, De Jager RL, Janniger CK, et al. Giant basal cell carcinoma with metastases and myelophthisic anemia. J Surg Oncol. 1986;33:223-226.
12. Beretta G, Molinari R. Metastasizing cutaneous basocellular carcinoma with myelophthisic anemia [Italian]. Tumori. 1970;56:175-181.
13. Elghissassi I, Mikou A, Inrhaoun H, et al. Metastatic basal cell carcinoma to the bone and bone marrow. Int J Dermatol. 2009;48:481-483.
14. Walling HW, Fosko SW, Geraminejad PA, et al. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev. 2004;23:389-402.
15. Lo JS, Snow SN, Reizner GT, et al. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol. 1991;24:715-719.
16. Pfeiffer P, Hansen O, Rose C. Systemic cytotoxic therapy of basal cell carcinoma. A review of the literature. Eur J Cancer. 1990;26:73-77.
17. Moeholt K, Aagaard H, Pfeiffer P, et al. Platinum-based cytotoxic therapy in basal cell carcinoma - a review of the literature. Acta Oncol. 1996; 35:677-682.
18. Jefford M, Kiffer JD, Somers G, et al. Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel. ANZ J Surg. 2004;74:704-705.
19. Sekulic A, Migden MR, Oro AE, et al. A pivotal study evaluating efficacy and safety of the hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic basal cell carcinoma. Melanoma Res 2011;21:e9.